Protests Over $2.6B Sepracor Deal Begin To Roll In
Just days after Dainippon Sumitomo Pharma made a $2.6 billion play for Sepracor Inc., shareholders are firing back with litigation accusing the company's directors of breaching their fiduciary duty by failing...To view the full article, register now.
Already a subscriber? Click here to view full article